Veracyte, Inc. ( VCYT) - Key Metrics
VCYT Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q1 | ? | ? | ? | ? |
| 2025Q4 | $1.78 | $0.52 | $0.66 | $0.61 |
| 2025Q3 | $1.68 | $0.24 | $0.57 | $0.53 |
| 2025Q2 | $1.66 | -$0.01 | $0.43 | $0.41 |
| 2025Q1 | $1.47 | $0.09 | $0.07 | $0.05 |
VCYT Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q1 | ? | ? |
| 2025Q4 | ? | 20.25 |
| 2025Q3 | ? | 35.31 |
| 2025Q2 | ? | -539.30 |
| 2025Q1 | ? | 82.08 |
VCYT Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2026Q1 | 1.26% | ? |
| 2025Q4 | 1.45% | ? |
| 2025Q3 | 1.55% | ? |
| 2025Q2 | 1.53% | ? |
| 2025Q1 | 0.15% | ? |
VCYT
Price: $48.69
52 week price:
Earnings Per Share: 1.08 USD
P/E Ratio: 36.76
Exchange: NGM
Sector: Healthcare
Industry: Diagnostics & Research
Country: United States
Volume: 321710
Ebitda: -5.2 millionMarket Capitalization: 3.2 billion